Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Baass

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Journal of Clinical Lipidology|May 16, 2017
The 9p21.3 locus and cardiovascular risk in familial hypercholesterolemiaMartine Paquette, Michael Chong, Yascara Grisel Luna Saavedra, et al.
Journal of Gastroenterology and Hepatology|October 10, 2024
Pancreatitis polygenic risk score is independently associated with all-cause acute pancreatitis risk in the UK BiobankSimon-Pierre Guay, Eloi Gagnon, Martine Paquette, et al.
Nutrition Research (New York, N.Y.)|April 3, 2022
Both low-fat and low-carbohydrate diets reduce triglyceride concentration in subjects with multifactorial chylomicronemia syndrome: a randomized crossover studyManon Fantino, Martine Paquette, Chantal Blais, et al.
Journal of Clinical Lipidology|March 5, 2024
Pancreatitis polygenic risk score is associated with acute pancreatitis in multifactorial chylomicronemia syndromeSimon-Pierre Guay, Martine Paquette, Amélie Taschereau, et al.
Scientific Reports|November 7, 2024
EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factorsValérie Lamantia, Simon Bissonnette, Myriam Beaudry, et al.
Clinical Biochemistry|July 15, 2025
DNA methylation levels are independently associated with prevalence of atherosclerotic cardiovascular disease in multifactorial chylomicronemia syndromeSimon-Pierre Guay, Martine Paquette, Amélie Taschereau, et al.
Clinical Biochemistry|January 5, 2025
DNA methylation levels may contribute to severe hypertriglyceridemia in multifactorial chylomicronemia syndromeSimon-Pierre Guay, Martine Paquette, Amélie Taschereau, et al.
The Canadian Journal of Cardiology|June 8, 2013
Regional distribution and metabolic effect of PCSK9 insLEU and R46L gene mutations and apoE genotypeZuhier Awan, Edgard E Delvin, Emile Levy, et al.
Journal of Geriatric Psychiatry and Neurology|March 23, 2018
Loss-of-Function PCSK9 Mutations Are Not Associated With Alzheimer DiseaseMartine Paquette, Yascara Grisel Luna Saavedra, Judes Poirier, et al.
Journal of Clinical Lipidology|September 12, 2025
Extreme lipoprotein(a) is a cardiovascular risk equivalent in heterozygous familial hypercholesterolemiaMartine Paquette, Bertrand Cariou, Simon-Pierre Guay, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Journal of Clinical Lipidology|May 16, 2017
The 9p21.3 locus and cardiovascular risk in familial hypercholesterolemiaMartine Paquette, Michael Chong, Yascara Grisel Luna Saavedra, et al.
Journal of Gastroenterology and Hepatology|October 10, 2024
Pancreatitis polygenic risk score is independently associated with all-cause acute pancreatitis risk in the UK BiobankSimon-Pierre Guay, Eloi Gagnon, Martine Paquette, et al.
Nutrition Research (New York, N.Y.)|April 3, 2022
Both low-fat and low-carbohydrate diets reduce triglyceride concentration in subjects with multifactorial chylomicronemia syndrome: a randomized crossover studyManon Fantino, Martine Paquette, Chantal Blais, et al.
Journal of Clinical Lipidology|March 5, 2024
Pancreatitis polygenic risk score is associated with acute pancreatitis in multifactorial chylomicronemia syndromeSimon-Pierre Guay, Martine Paquette, Amélie Taschereau, et al.
Scientific Reports|November 7, 2024
EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factorsValérie Lamantia, Simon Bissonnette, Myriam Beaudry, et al.
Clinical Biochemistry|July 15, 2025
DNA methylation levels are independently associated with prevalence of atherosclerotic cardiovascular disease in multifactorial chylomicronemia syndromeSimon-Pierre Guay, Martine Paquette, Amélie Taschereau, et al.
Clinical Biochemistry|January 5, 2025
DNA methylation levels may contribute to severe hypertriglyceridemia in multifactorial chylomicronemia syndromeSimon-Pierre Guay, Martine Paquette, Amélie Taschereau, et al.
The Canadian Journal of Cardiology|June 8, 2013
Regional distribution and metabolic effect of PCSK9 insLEU and R46L gene mutations and apoE genotypeZuhier Awan, Edgard E Delvin, Emile Levy, et al.
Journal of Geriatric Psychiatry and Neurology|March 23, 2018
Loss-of-Function PCSK9 Mutations Are Not Associated With Alzheimer DiseaseMartine Paquette, Yascara Grisel Luna Saavedra, Judes Poirier, et al.
Journal of Clinical Lipidology|September 12, 2025
Extreme lipoprotein(a) is a cardiovascular risk equivalent in heterozygous familial hypercholesterolemiaMartine Paquette, Bertrand Cariou, Simon-Pierre Guay, et al.
Pageof 10